HKSE · 0575.HK
Regent Pacific Group Limited
HK$0.87+HK$0.02 (+2.35%)
Regent Pacific Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.69% below the high.
Loading market information…
HKSE · 8225.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 28, 2026, 10:10 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
China Health Group Inc.’s quoted price sits in the lower half of its reported 52-week range, 59.76% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow China Health Group Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers pharmacodynamics and clinical research of drugs. China Health Group Inc. was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. The company was founded in 1998 and is headquartered in Beijing, China.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:02 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
HK$0.87+HK$0.02 (+2.35%)
Regent Pacific Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.69% below the high.
HK$0.17+HK$0.00 (+0.61%)
Grand Brilliance Group Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 7.78% below the high.
HK$0.23-HK$0.00 (-0.86%)
PuraPharm Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 47.73% below the high.
HK$0.65-HK$0.08 (-10.96%)
King International Investment Limited’s quoted price sits in the lower half of its reported 52-week range, 59.12% below the high.
HK$0.19-HK$0.02 (-10.38%)
Kelfred Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 65.45% below the high.
HK$0.25-HK$0.00 (-0.41%)
China Regenerative Medicine International Limited’s quoted price sits in the lower half of its reported 52-week range, 62.88% below the high.
HK$0.07-HK$0.00 (-1.35%)
China Healthwise Holdings Ltd.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
HK$0.45+HK$0.01 (+2.27%)
Universal Health International Group Holding Limited’s quoted price sits in the lower half of its reported 52-week range, 91.6% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
